D-Wave Quantum's 44% Weekly Rally: Government Funding and Record Orders Collide with a Tripled Net Loss

D-Wave Quantum stock jumps on $100M government award and record bookings, but Q1 revenue drops 81% and net loss triples, creating a stark contrast with soaring share price.

Rarely does a stock jump 44% in a week while its net loss triples and revenue collapses by more than 80%. That is the contradictory picture emerging from D-Wave Quantum, whose shares closed at the equivalent of €25.21 on Friday — a gain of 13.6% on the day — on volume that topped 140 million shares, more than three times the daily average. The move extended a blistering weekly advance and pushed the stock well above its 200-day moving average, yet the underlying financials have rarely looked more fragile.

Behind the surge lies a $100 million commitment from the U.S. government, awarded through the National Institute of Standards and Technology (NIST) as part of a $2 billion quantum-computing initiative shared among nine companies. In return, Washington takes a minority equity stake in D-Wave, a deal TD Cowen ranks as one of the three biggest wins of the program alongside Rigetti Computing and GlobalFoundries. The injection provides a crucial liquidity buffer — the company reports a net cash position of roughly $553 million — but it comes with a steep dilution cost: the share count has ballooned by 226% since the start of the AI era.

The same week also delivered what D-Wave called a record in bookings. First-quarter 2026 orders hit $33.4 million, fueled by a $20 million system sale and a $10 million corporate agreement. More importantly, the company's Advantage2 system — packing over 4,400 qubits — has moved from pilot to production: it is now installed at Davidson Technologies in Alabama, where the U.S. defense contractor is using it for radar detection and logistics optimization. D-Wave's dual strategy of offering both annealing and gate-model quantum computers gives it a differentiated position, and the integration of recently acquired Quantum Circuits broadens that capability further.

Yet the income statement tells a very different story. Revenue in the first quarter plunged to $2.86 million from $15.0 million a year earlier, while the net loss widened from $5.4 million to $18.4 million. Gross margin fell sharply to 63.6% from 92.5%, a casualty of integration costs and shifting revenue recognition. The disparity between soaring bookings and cratering revenue highlights how long it takes for new orders to convert into recognized sales — a lag that investors will be watching closely.

Adding a note of caution, the company's chief people officer Sophie Ames sold 23,025 shares on May 20 via a pre-arranged 10b5-1 plan. Such sales are routine, but they rarely bolster sentiment during a week of such extreme price action.

Wall Street remains largely bullish despite the mixed signals. Benchmark reiterated a buy rating and a $35 price target on Friday, while Needham and Cantor Fitzgerald each hold $40 targets. Of the 15 analysts covering D-Wave, 14 recommend buying and only one says sell. The consensus price target stands at roughly $34.67, implying further upside from current levels, though the stock still trades about 35% below its 52-week high.

Looking ahead, the company has its investor day — themed "The D-Wave Difference" — scheduled for June 1, followed by appearances at conferences hosted by TD Cowen (May 28), Baird (June 3), and Rosenblatt (June 10). With the broader quantum sector also gaining momentum — Rigetti and IonQ posted double-digit gains last week — the stage is set for D-Wave to either validate its narrative or face renewed skepticism. The core question remains whether record bookings can eventually translate into the kind of revenue growth that matches the stock's valuation, or whether the twin forces of dilution and operating losses will ultimately weigh on the rally.